PI3Kγ pathway contributes to neuroinflammation and neuronal death induced by Zika virus infection
Danielle Cunha Teixeira,Gabriel Campolina-Silva,Fernanda Martins Marim,Felipe Rocha da Silva Santos,Celso Martins Queiroz-Junior,Pedro Augusto Carvalho Costa,Fernanda de Lima Tana,Luiz Pedro Costa-Souza,Jordane Clarisse Pimenta,Julia Gomes Carvalho,Vinicius Amorim Beltrami,Felipe Emanuel Oliveira Rocha,Drielle Viana Vieira,Evandro Goncalves Dornelas,Giovana Cougo Ferreira,Felipe Ferraz Dias,Pedro Pires Goulart Guimaraes,Vinicius Toledo Ribas,Antonio Lucio Teixeira,Aline Silva Miranda,Mauro Martins Teixeira,Daniele da Gloria Souza,Vivian Vasconcelos Costa
DOI: https://doi.org/10.1101/2024.12.20.629712
2024-12-22
Abstract:Zika virus (ZIKV) is an emerging arbovirus belonging to the Flaviviridae family and Orthoflavivirus genus, with a pronounced tropism for the central nervous system (CNS), where it induces neuroinflammation and neuronal death. ZIKV is known to exploit host cellular mechanisms, including the activation of survival pathways such as the PI3K/AKT signaling cascade, to evade apoptosis and enhance its replication. The phosphatidylinositol 3-kinase γ (PI3Kγ) pathway regulates critical cellular processes, including differentiation, recruitment, and survival, and is abundantly expressed in both brain tissue and leukocytes. This study aimed to investigate the role of the PI3Kγ pathway during ZIKV infection. Primary neuronal cultures from PI3Kγ-deficient mice (PI3Kγkd/kd) and human neuroblastoma SH-SY5Y cells treated with the PI3Kγ inhibitor AS605240 were infected with ZIKV to assess the impact of PI3Kγ signaling on viral replication and neuronal survival. Additionally, interferon α/β receptor knockout (A129) mice were treated with AS605240 either before or after ZIKV infection to evaluate the pathway's role in neuroinflammation. In vitro, both genetic ablation and pharmacological inhibition of PI3Kγ suppressed ZIKV replication and prevented neuronal death. In vivo, mice treated with the PI3Kγ inhibitor exhibited enhanced protection against ZIKV infection, characterized by reduced viral load, and diminished brain and optic nerve damage. This neuroprotective effect correlated with altered astrocyte and microglia activation, marked by reduced TNF production in microglia. Furthermore, inhibition of PI3Kγ curtailed the recruitment and activation of CD8+ T cells and decreased the production of pro-inflammatory mediators, including IFN-γ and IL-17, in the brains of ZIKV-infected mice. These findings suggest that PI3Kγ activation facilitates ZIKV infection and exacerbates neuroinflammation. Pharmacological inhibition of the PI3Kγ pathway may offer therapeutic benefits by limiting viral replication and alleviating neuroinflammatory responses during ZIKV infection.
Immunology